TRT claims on TikTok: separating hype from clinical evidence

What did @dr.hrallysom_neyrelles actually say?

Bluntly: nothing coherent. The transcript is word salad. Phrases like "different attachings" and "different transferings" repeat without meaning, and no actual medical claim survives a close read. This is not a paraphrase. That is the content.

The video is tagged under TRT and hormone optimization, which is how it landed in our review queue. But the creator never mentions testosterone, hormones, hypogonadism, dosing, labs, or any clinical concept. The caption hashtags reference Brazilian labor law terms, "verbasrescisórias" means severance pay, and "multa40porcentofgts" refers to a statutory FGTS penalty. The content and category are completely mismatched, and the transcript itself does not hold up as speech in any recognizable language or clinical framework.

It is possible this video was auto-captioned from Portuguese and the transcription failed catastrophically, or that the audio was garbled. Either way, there is no factual content to evaluate on TRT or any medical topic.

Does the science back this up?

There is no claim here to test against the literature. You cannot fact-check a sentence like "we have to wear different attachings." So instead, here is what the actual science says about TRT, since that is the category this video was filed under.

Testosterone replacement therapy for hypogonadism has a well-established evidence base. A 2018 meta-analysis by Corona et al. in the Journal of Sexual Medicine confirmed benefits on sexual function, body composition, and mood in men with confirmed hypogonadism, defined as low serum testosterone plus clinical symptoms. The Testosterone Trials, a coordinated set of seven studies published in the New England Journal of Medicine between 2016 and 2017, showed modest but real improvements in sexual desire, bone density, and anemia in older hypogonadal men. What the science does not support is treating TRT as a general wellness or anti-aging intervention in men with normal testosterone levels. That distinction matters, and any creator in this space who skips past it is doing their audience a disservice.

What did they get wrong (or right)?

Getting something wrong requires making a claim first. This video did not make one, at least not in any recoverable form from the transcript provided.

What we can say is that the tagging is wrong. Filing a video under TRT when the hashtags are about Brazilian employment law, and when the speech itself is incoherent, creates a real problem. Platforms like TikTok surface content by category. Viewers searching for credible hormone health information may land on this video and assume it contains something useful. That is a harm even without a specific false claim. It wastes the viewer's time at minimum, and at worst it signals that this content space is being gamed or mislabeled.

We cannot give credit for anything said here, because nothing was said. If the video was intended to be about labor law, and the transcript is a bad machine translation or corrupted audio, then this is a platform quality issue, not a misinformation issue per se. But the result is the same: zero clinical value, wrong category, 200,000 views.

What should you actually know?

If you found this video looking for TRT information, here is what is actually worth knowing from the clinical record.

TRT is a legitimate treatment for diagnosed hypogonadism, not a shortcut for men who feel tired or want to gain muscle. Diagnosis requires at minimum two morning serum testosterone measurements below established thresholds, typically 300 ng/dL in most U.S. guidelines, combined with symptoms. The Endocrine Society's 2018 clinical practice guidelines are the reference standard here.

Delivery methods, gels, injections, patches, and pellets, differ in pharmacokinetics, adherence rates, and side effect profiles. No single method is universally superior. Pellegrini et al. (2020, Andrology) found that patient preference and lifestyle factors drive adherence more than clinical outcomes in most stable patients.

Anyone claiming TRT will cure a specific disease, or recommending a specific dose publicly without knowing a patient's labs, is operating outside evidence-based medicine. Full stop.